Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 14 Issue 4, April 2012

Lrig1 controls proliferation within the intestinal crypt by inhibiting ErbB signalling.p401

Comment

  • Although the road to cell therapeutics is rife with uncertainties — scientific, clinical and economic — its success could transform medicine. Five years into its mission, the California Institute of Regenerative Medicine is laying a foundation for this new form of medical treatment.

    • Alan Trounson
    • Natalie D. DeWitt
    Comment

    Advertisement

Top of page ⤴

Turning Points

Top of page ⤴

News & Views

  • Microtubule-based mRNA transport participates in the establishment of cell asymmetries. An in vitro reconstitution assay demonstrates that localization signals present in an mRNA influence motor copy number on single RNA molecule cargoes, ultimately leading to highly polarized distributions of transcripts.

    • Michael Doyle
    • Michael A. Kiebler
    News & Views
  • Meiotic recombination produces physical linkages between homologous chromosomes that enable their segregation to opposite poles during meiosis I. In the absence of recombination, chromosomes mis-segregate, resulting in aneuploidy associated with severe birth defects. A recent study provides exciting insights into how recombination is fine-tuned to enforce a robust meiotic program.

    • Chitra V. Kotwaliwale
    News & Views
  • The transcription factor Twist1 is overexpressed in tumours and can induce the epithelial–mesenchymal transition, resulting in increased invasiveness. Twist1 is now shown to regulate cancer cell migration and invasion in three-dimensional environments by activating the RAC1 GTPase through suppression of a let-7 microRNA family member.

    • Geoffrey Childs
    • Jeffrey E. Segall
    News & Views
  • Cellular senescence is a stable proliferation arrest induced by triggers such as short telomeres, activated oncogenes and genotoxic stress. Two studies show that cellular senescence induced by genotoxic stress depends on chronic DNA-damage signalling from irreparable damage to telomeres. Hence, dysfunctional or damaged telomeres are the initiators of multiple modes of senescence.

    • John van Tuyn
    • Peter D. Adams
    News & Views
Top of page ⤴

Research Highlights

Top of page ⤴

Article

  • Formation and fission of large membrane-bound carriers at the Golgi requires coordinated action by a myriad of proteins, including PI(4)KIIIβ and CtBP1-S/BARS. Corda and colleagues reveal that the scaffold protein 14-3-3γ bridges BARS to PI(4)KIIIβ, thus mechanistically linking carrier budding and tubulation with tubule fission.

    • Carmen Valente
    • Gabriele Turacchio
    • Daniela Corda
    Article
  • D’Adda di Fagagna and colleagues observe that, after genotoxic treatment of cells and mice, unrepaired DNA-damage foci and DNA-damage signalling persist at telomeres. They show that introducing the telomeric protein TRF2 near a double-strand break elsewhere on the chromosomes prevents repair. Unrepaired foci are also observed at telomeres of ageing animals, suggesting a role for TRF2 in senescence establishment.

    • Marzia Fumagalli
    • Francesca Rossiello
    • Fabrizio d’Adda di Fagagna
    Article
  • Yang and colleagues delineate a pathway that controls cell migration in 3D environments following Twist1-mediated epithelial-to-mesenchymal transition. They show that Twist1 represses the let-7i microRNA, leading to upregulation of the RAC1-activating factors NEDD9 and DOCK3, and inducing mesenchymal-mode motility and tumour invasion in vivo.

    • Wen-Hao Yang
    • Hsin-Yi Lan
    • Muh-Hwa Yang
    Article
  • The SCF ubiquitin ligase subunit Fbxw7 is a tumour suppressor that is mutated in many cancers. Pagano and colleagues now show that in multiple myeloma, Fbxw7α instead functions as a pro-survival factor by activating the NF-κB pathway through the ubiquitin-mediated degradation of p100, an NF-κB pathway inhibitor.

    • Luca Busino
    • Scott E. Millman
    • Michele Pagano
    Article
Top of page ⤴

Letter

Top of page ⤴

Search

Quick links